Skip to content
Study details
Enrolling now

Sympatholysis in Chronic Kidney Disease

Emory University
NCT IDNCT02411773ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

110

Study length

about 12 years

Ages

18–75

Locations

1 site in GA

What this study is about

Researchers are testing whether a treatment can improve exercise capacity and lower blood pressure during exercise in people with chronic kidney disease. The trial will compare different treatments, including stretching, exercise training, a placebo, and sodium bicarbonate, to see which one works best.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Control to Exercise (Stretching)
  • 2.Participate in Exercise Training
  • 3.Take Placebo
  • +1 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

sodium bicarbonate

Drug routes

oral (Oral Tablet)

Body systems

Renal